Revolution Medicines Inc Working Capital to Net Assets Ratio
Revolution Medicines Inc working capital to net assets ratio. Revolution Medicines Inc (RVMD) has a Working Capital to Net Assets ratio of 141.0% as of June 2026. Working capital of $3.67 Billion (current assets of $4.03 Billion minus current liabilities of $354.06 Million) is measured against net assets of $2.61 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base. Check Revolution Medicines Inc tangible equity quality to evaluate the tangible quality of the company's equity base.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Working Capital to Net Assets Ratio of Revolution Medicines Inc (2017–2025)
Working capital to net assets ratio of Revolution Medicines Inc from 2017 to 2025. This chart shows how Revolution Medicines Inc's Working Capital to Net Assets ratio has evolved across 9 annual periods from 2017 to 2025. As of June 2026, the ratio stands at 141.0%, reflecting working capital of $3.67 Billion against net assets of $2.61 Billion USD. See operational self-sufficiency of Revolution Medicines Inc to measure how many days the company can operate on defensive assets alone.
Revolution Medicines Inc Working Capital to Net Assets Ratio by Year (2017–2025)
Revolution Medicines Inc working capital to net assets ratio by year from 2017 to 2025. The table below presents the year-by-year Working Capital to Net Assets ratio for Revolution Medicines Inc from 2017 to 2025, covering 9 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see balance sheet size of Revolution Medicines Inc.
| Year | WC/NA Ratio | Working Capital (USD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 109.4% | $1.78 Billion | $1.63 Billion | $2.08 Billion | $290.42 Million | ▲ +13.9 pp |
| 2024 | 95.5% | $2.16 Billion | $2.27 Billion | $2.33 Billion | $163.91 Million | ▲ +0.5 pp |
| 2023 | 95.0% | $1.74 Billion | $1.83 Billion | $1.88 Billion | $143.85 Million | ▲ +7.7 pp |
| 2022 | 87.3% | $598.20 Million | $685.19 Million | $660.18 Million | $61.98 Million | ▼ -0.6 pp |
| 2021 | 87.9% | $529.42 Million | $602.57 Million | $589.77 Million | $60.35 Million | ▲ +2.1 pp |
| 2020 | 85.7% | $406.95 Million | $474.68 Million | $454.12 Million | $47.18 Million | ▲ +26.1 pp |
| 2019 | 59.6% | $90.93 Million | $152.53 Million | $133.98 Million | $43.05 Million | ▲ +2.8 pp |
| 2018 | 56.8% | $54.88 Million | $96.66 Million | $85.43 Million | $30.55 Million | ▲ +16.1 pp |
| 2017 | 40.7% | $1.84 Million | $4.53 Million | $9.44 Million | $7.60 Million | — |